drugset / Trial / NCT01490216

Pilot Study of Lisdexamfetamine for Treatment of Cocaine Dependence

NCT01490216

Phase 1 Terminated 43 enrolled University of Minnesota
NaSingle-groupOpen-labelBasic science

Summary

The purpose of this study is to evaluate ideal dose or lisdexamfetamine and tolerability, plus reduction in cocaine use and craving.

Timeline

Start
2011-07
Primary completion
2013-01
Completion
2013-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Lisdexamfetamine Other / unclassified 20 mg
Subject Lisdexamfetamine Other / unclassified 70 mg

Indications